Drug Database
Back to search

Netherlands· NL-fabd247a6130

Cholestagel 625 mg, filmomhulde tabletten

A colesevelam product containing colesevelamhydrochloride, registered in Netherlands by CHEPLAPHARM Arzneimittel GmbH. The same ATC class is registered in 14 of our 19 countries.

ATC C10AC04

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedCholestagel 625 mg, filmomhulde table…ATCC10AC04REGISTER NO.NL-fabd247a6130PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about colesevelamhydrochlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Colesevelam is registered in 14 of 19 countries.

Countries holding a registration under ATC C10AC04 (colesevelam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 8 of them publish a price we can compare per daily dose
Search colesevelam products by name

Colesevelam · ATC C10AC04

14 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of colesevelam costs, country by country.

Normalised to the WHO defined daily dose (3.75 g), the median price runs from $1.57 in United States to $5.96 in Spain — a ×3.8 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
  • US figures are pharmacy acquisition cost (CMS NADAC), not retail
Open the full comparison — free accountDrug prices for market access

Colesevelam · price per daily dose (3.75 g)

USD · FX 28 Sept 2026

  • ES Spain$5.96
  • US United States$1.57 (acquisition cost)
Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
COLESEVELAMHYDROCHLORIDE
Manufacturer
CHEPLAPHARM Arzneimittel GmbH
Country
Netherlands (NL)
ATC code
C10AC04
ATC class
Colesevelam
Defined daily dose
3.75 g, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/03/268

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

63 interactions on record for colesevelam.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check colesevelam against other medicinesHow interaction checks work

Colesevelam · interactions on record

63 records

  • 5 severe
  • 58 moderate

Most severe, free to view

  • BexaroteneL01XF03severe
  • BexarotenL01XX25severe
  • Mycophenolic acidL04AA06severe
  • TeriflunomidL04AA31severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Colesevelam in 4 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All colesevelam products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f7e45209-fbe0-4dd5-88ce-f5cc6f1c6c52
GET /v1/drugs/f7e45209-fbe0-4dd5-88ce-f5cc6f1c6c52?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/cholestagel-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Colesevelam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71771",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "HYPROMELLOSE (E 464)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ZWART (E 172)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "MONOGLYCERIDEN, GEDIACETYLEERD",
    "PROPYLEENGLYCOL (E 1520)",
    "SILICIUMDIOXIDE (E 551)",
    "ZWARTE INKT"
  ],
  "substances": [
    "COLESEVELAMHYDROCHLORIDE"
  ],
  "leaflet_url": null,
  "authorised_at": "2004/03/10",
  "procedure_number": "EMEA/H/C/000512",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/03/268",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about colesevelam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console